Platinum corporate sponsors
AbbVie is a global, research-based biopharmaceutical company formed in 2013 following separation from Abbott Laboratories. The company’s mission is to use its expertise, dedicated people and unique approach to innovation to develop and market advanced therapies that address some of the world’s most complex and serious diseases. Together with its wholly-owned subsidiary, Pharmacyclics, AbbVie employs more than 28,000 people worldwide and markets medicines in more than 170 countries. For further information on the company and its people, portfolio and commitments, please visit www.abbvie.co.uk
Almirall are an International Pharmaceutical company based on innovation and committed to health, based in Barcelona, Spain. Almirall research, develop, produce and market proprietary R&D medicines and those under licence with the aim of improving people’s health and well being. Almirall UK are currently focused on a Dermatology portfolio.
Established in 2009, Aspire is a privately owned British company offering a range of medicines, medical devices, diagnostics and OTC products. Each product is carefully thought through, offering value and differentiation to patients and healthcare professionals.
Dating back to 1961, Galderma is now present in over 100 countries, with 35 affiliates and more than 6,000 employees and has an extensive product portfolio of medical solutions to treat a range of dermatological conditions. The company partners with health care professionals around the world to meet the skin health needs of people throughout their lifetime. Galderma is a leader in research and development of scientifically-defined and medically-proven solutions for the skin, hair and nails. For more information, please visit www.galderma.co.uk
Immunology Company Information At Janssen, innovation is in our nature – we strive to continually deliver pioneering solutions in immunology through dedicated research and collaboration. • We are proud to have one of the strongest treatment portfolios for some of the most common immune and inflammatory diseases across dermatology, rheumatology and gastroenterology. • Janssen invests in an extensive presence and multiple partnerships across Europe and Middle East and Africa (EMEA) region to support progress in immunology. • We make R&D investments in the field of Immunology of more than €1.5 billion annually
Date of Preparation: April 2018 Job Bag: PHGB/GUS/0418/0002
La Roche Posay
LEO Pharma is a global pharmaceutical company dedicated to helping people achieve healthy skin. Headquartered in Denmark, with 4,600 employees in 61 countries our products are sold in over 100 countries. Being owned by the LEO Foundation, with no external shareholders, profits are reinvested to benefit patients.
Within dermatology LEO delivers treatments for psoriasis, infected eczema and skin infections. LEO Pharma also delivers treatments for thrombosis (blood clotting). LEO Pharma is also committed to helping healthcare providers deliver quality patient care through innovative redesign of healthcare services in the evolving NHS along with the provision of comprehensive patient support and education.
Lilly is a global healthcare leader that unites caring with discovery to make life better for people around the world. We were founded more than a century ago by a man committed to creating high-quality medicines that meet real needs, and today we remain true to that mission in all our work. Across the globe, Lilly employees work to discover and bring life-changing medicines to those who need them, improve the understanding and management of disease, and give back to communities through philanthropy and volunteerism.
To learn more about Lilly, please visit us at www.lilly.co.uk
Novartis transform patients’ lives by targeting progressive illnesses in the Specialty Dermatology and Rheumatology fields, where there are high unmet medical needs.
More information at www.novartis.co.uk
Thornton and Ross
T+R Derma, incorporating the Cetraben and Zeroderma brands, offers the most comprehensive choice of emollients for patients with dry skin conditions. Clinically effective, cosmetically acceptable, Cetraben helps provide patients with confidence and freedom from eczema and dry skin. Zeroderma offers similar formulations to leading brands with cost savings of up to 37% without compromising on patient care.
UCB Pharma Ltd
UCB is a global biopharmaceutical company focused on the discovery and development of innovative medicines and solutions to transform the lives of people and create value for specific patient populations living with severe diseases in dermatology, rheumatology and neurology.
Address: 208 Bath Road, Slough, Berkshire, SL1 3WE
Tel: 01753 534 655
Gold corporate sponsors
Alliance Pharmaceuticals Ltd together with KELO-COTE© is delighted to support the BDNG. The KELO-COTE© patented range of products includes a gel, a spray and UV gel which are used for the treatment and prevention of keloid and hypertrophic scars. KELO-COTE©’s advanced formula has been clinically proven to help flatten, smooth and reduce the redness associated with scarring. For more information about our company and range of KELO-COTE© products please visit www.kelocote.co.uk, email email@example.com, or call us on 01249 466966
WE BELIEVE IN THE LIFE-CHANGING POWER OF DERMATOLOGICAL SKINCARE
Our skin is much more than our body’s protective shield. It is alive. Inextricably and intimately linked to how we feel. The physical affects the emotional. If our skin has a problem, so do we. We make skin concerns our concern.
We have a 100-year heritage of dedication to skincare science. The research of expert dermatologists matters, developing new active ingredients matters, new clinically proven solutions really matter.
We are constantly in pursuit of scientific breakthroughs and new answers to age-old questions. Enabling tangible results and visible confidence.
The effects of skincare are not just skin deep. Stopping an itch means more than preventing the scratch. Soothing acne means more than clearing pores. Solve your skin problem; your skin feels better, you feel better.
Biofrontera is a biopharmaceutical company specialized in the field of dermatology. Our particular focus lies in the management of non-melanoma skin cancers (NMSC) through both conventional and daylight-mediated photodynamic therapy. These are areas in which we have developed considerable scientific and clinical expertise over a period of many years. Founded in 1997, Biofrontera currently employs around 130 staff worldwide.
Bristol Myers Squibb
Bristol Myers Squibb is a global biopharmaceutical company whose mission is to discover, develop and deliver innovative medicines that help patients prevail over serious diseases.
We are a small specialist pharmaceutical company dedicated to the field of dermatology. Our aim is to provide cost-effective treatments for all prescribers and to assist CCG’s and Health Trusts to maximise their budgets. Our products include Ultrabase emollient and Sebco Ointment. Website: www.dermauk.co.uk
For over 50 years, Dermal have been developing highly effective, cosmetically elegant and clinically proven treatments for application to the skin. It is the performance of the whole formulation that makes the difference.
Dermal’s popular dermatology medicines are further supported by our commitment towards prescribers and patients, including educational items to empower patients in the management of their skin condition.
We remain dedicated to building on Dermal’s history, as a specialist, independent, British pharmaceutical company, promoting successful topical innovation and supporting dermatology for the benefit of future generations. Website: www.dermal.co.uk
schülke – experts in infection prevention – offer a range of innovative skin and woundcare products, designed to meet the needs of both primary and secondary care. New octenicare® Repair Creme, is specifically formulated to support natural regeneration of the skin following varicose eczema flares, incontinence associated dermatitis, under compression bandages on the lower limbs, to protect the skin in skin folds and in the non-active phase of atopic dermatitis. It can be used in conjunction with octenilin® wound irrigation solution and octenilin® wound gel as part of the wound healing process, particularly at the epithelisation stage.
schülke also supports health professionals by offering a range of online evidence-based CPD courses: https://www.schuelke-learning.com/course/skin-integrity-in-practice